Trump Administration's Shift on Drug Policy: Embracing Psychedelics and Cannabis
In a notable shift from previous GOP stances, the Trump administration is now supporting research into psychedelics and reconsidering marijuana's legal status.
Editorial Staff
1 min read
Updated 16 days ago
On April 23, 2026, reports emerged highlighting a significant change in the Republican Party's approach to drug policy under the Trump administration.
This new direction marks a departure from the long-standing 'Just Say No' campaign, as the administration is actively funding research into psychedelics.
Additionally, there are efforts to reschedule marijuana, indicating a potential reevaluation of its legal classification.